Affimed N.V. (AFMD): Price and Financial Metrics
AFMD Price/Volume Stats
Current price | $1.15 | 52-week high | $8.95 |
Prev. close | $1.08 | 52-week low | $1.03 |
Day low | $1.05 | Volume | 347,500 |
Day high | $1.16 | Avg. volume | 315,645 |
50-day MA | $2.21 | Dividend yield | N/A |
200-day MA | $4.08 | Market Cap | 18.52M |
AFMD Stock Price Chart Interactive Chart >
Affimed N.V. (AFMD) Company Bio
Affimed NV is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. The company was founded in 2000 and is based in Heidelberg, Germany.
AFMD Price Returns
1-mo | -3.36% |
3-mo | -66.08% |
6-mo | -77.45% |
1-year | -80.17% |
3-year | -97.14% |
5-year | -96.09% |
YTD | -3.36% |
2024 | -80.96% |
2023 | -49.60% |
2022 | -77.54% |
2021 | -5.15% |
2020 | 112.41% |
Continue Researching AFMD
Want to see what other sources are saying about Affimed NV's financials and stock price? Try the links below:Affimed NV (AFMD) Stock Price | Nasdaq
Affimed NV (AFMD) Stock Quote, History and News - Yahoo Finance
Affimed NV (AFMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...